NDC product
Maxi Nicotine
NDC 11822-3317 · Rite Aid Corporation
Key facts
| Product NDC | 11822-3317 |
|---|---|
| Proprietary name | Maxi Nicotine |
| Nonproprietary name | nicotine polacrilex |
| Substances | NICOTINE |
| Dosage form | LOZENGE |
| Route | ORAL |
| Labeler | Rite Aid Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA209206 |
| Pharmacologic classes | Cholinergic Nicotinic Agonist [EPC], Nicotine [CS] |
| Marketing start | Nov 29, 2019 |
| Marketing end | Nov 29, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory